Similar Papers

Paper Title
Journal
Date
Author
Anticancer effects of ABTL0812, a clinical stage drug inducer of autophagy-mediated cancer cell death, in glioblastoma models.
Andrea Mancini ... Giovanni Luca Gravina
Frontiers in Oncology | VOL. 12
Andrea Mancini, et. al.Andrea Mancini ... Giovanni Luca Gravina
02 Nov 2022
The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase.
Tatiana Erazo ...
Clinical Cancer Research | VOL. 22
Tatiana Erazo, et. al.Tatiana Erazo ...
12 May 2016
Data from The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase
Guillermo Velasco ...
-
Guillermo Velasco, et. al.Guillermo Velasco ...
31 Mar 2023
Data from The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase
José A García-Martínez ...
-
José A García-Martínez, et. al.José A García-Martínez ...
31 Mar 2023
View more papers

More From: Frontiers in Oncology

Paper Title
Journal
Date
Author
Exploration of treatment strategies for cerebral cavernous malformations: two case reports on non-resection treatment and literature review
Yibo Han ... Yong Wang
Frontiers in Oncology | VOL. -
Yibo Han, et. al.Yibo Han ... Yong Wang
28 Jan 2025
High Ki67 expression, HER2 overexpression, and low progesterone receptor levels in high-grade DCIS: significant associations with clinical practice implications
Hossein Schandiz ... Jürgen Geisler
Frontiers in Oncology | VOL. -
Hossein Schandiz, et. al.Hossein Schandiz ... Jürgen Geisler
28 Jan 2025
Asymptotic analysis of mathematical model describing a new treatment of breast cancer using AZD9496 and palbociclib
Ophir Nave
Frontiers in Oncology | VOL. -
Ophir NaveOphir Nave
28 Jan 2025
Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samples
Nicola Cosgrove ... Sinead Toomey
Frontiers in Oncology | VOL. -
Nicola Cosgrove, et. al.Nicola Cosgrove ... Sinead Toomey
28 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.